Send us Feedback

Progen Pharmaceuticals (PGLA)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Bell Potter faces class action
WA Business News  Dec 2  Comment 
More than 50 former clients of Bell Potter Securities, including some from Perth, have launched a class action against the stockbroking firm alleging it engaged in wrongful conduct by encouraging them to invest in Progen Phamaceuticals.
Delisting of Securities of Progen Pharmaceuticals Limited, First National Bancshares Inc. and United American Healthcare Corporation From The NASDAQ Stock Market
Globe Newswire  Jul 15  Comment 
NEW YORK, July 15, 2010 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the ordinary shares of Progen Pharmaceuticals Limited. Progen Pharmaceuticals Limited's stock was suspended on July 2, 2010 and has not traded on
Progen says European patent granted
Sydney Morning Herald  May 18  Comment 
Cancer drug developer Progen Pharmaceuticals Ltd says a European patent has been granted for a new technology therapeutic compound that it has licensed.
Progen to present preclinical data on cancer inhibitor
Life Science Lab  Oct 14  Comment 
PROGEN Pharmaceuticals Limited has announced new preclinical data on PG545, a dual antiangiogenic and anti-heparanase inhibitor, will be presented at an international cancer therapeutics conference.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Progen Pharmaceuticals (PGLA):
 




References

Retrieved from "http://www.wikinvest.com/stock/Progen_Pharmaceuticals_(PGLA)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki